NAE1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.306400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.092400E-01
Normal-vs-Stage2
9.881200E-01
Normal-vs-Stage3
3.498800E-01
Normal-vs-Stage4
5.281800E-01
Stage1-vs-Stage2
8.851400E-01
Stage1-vs-Stage3
2.597200E-01
Stage1-vs-Stage4
5.212600E-01
Stage2-vs-Stage3
2.755000E-01
Stage2-vs-Stage4
4.099200E-01
Stage3-vs-Stage4
1.985030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.115600E-01
Normal-vs-AfricanAmerican
8.780800E-01
Normal-vs-Asian
5.675400E-01
Caucasian-vs-AfricanAmerican
9.442800E-01
Caucasian-vs-Asian
2.650600E-01
AfricanAmerican-vs-Asian
4.040000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.967000E-01
Normal-vs-Female
8.285400E-01
Male-vs-Female
3.978800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.803400E-01
Normal-vs-Age(41-60Yrs)
6.124800E-01
Normal-vs-Age(61-80Yrs)
9.326600E-01
Normal-vs-Age(81-100Yrs)
6.223200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.403000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.266600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.530200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.648500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.424600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.611000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.706200E-01
Normal-vs-Daily Drinker
8.266000E-01
Normal-vs-Weekly Drinker
9.604000E-01
Normal-vs-Occasional Drinker
2.919200E-01
Normal-vs-Social Drinker
9.530600E-01
Non Drinker-vs-Daily Drinker
7.548800E-01
Non Drinker-vs-Weekly Drinker
5.301000E-01
Non Drinker-vs-Occasional Drinker
3.077400E-03
Non Drinker-vs-Social Drinker
3.698400E-01
Daily Drinker-vs-Weekly Drinker
7.666600E-01
Daily Drinker-vs-Occasional Drinker
2.092500E-02
Daily Drinker-vs-Social Drinker
6.126400E-01
Weekly Drinker-vs-Occasional Drinker
6.888200E-02
Weekly Drinker-vs-Social Drinker
8.622000E-01
Occasional Drinker-vs-Social Drinker
7.097500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.183400E-01
Normal-vs-Grade 2
6.235600E-01
Normal-vs-Grade 3
8.517800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.135600E-01
Grade 1-vs-Grade 3
1.067190E-01
Grade 1-vs-Grade 4
3.183400E-01
Grade 2-vs-Grade 3
8.077900E-02
Grade 2-vs-Grade 4
6.235600E-01
Grade 3-vs-Grade 4
8.517800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.611000E-01
Normal-vs-NonDiabetic
9.233800E-01
Diabetic-vs-NonDiabetic
3.987000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.050000E-01
Normal-vs-NoPancreatitis
9.126000E-01
Pancreatitis-vs-NoPancreatitis
3.555000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.551600E-01
Normal-vs-N1
9.627200E-01
N0-vs-N1
7.689700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.717000E-01
Normal-vs-TP53-NonMutant
8.214200E-01
TP53-Mutant-vs-TP53-NonMutant
5.180000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
